IQVIA Holdings Inc Total Liabilities
IQVIA Holdings Inc total liabilities. Based on the latest financial reports, IQVIA Holdings Inc (IQV) has total liabilities worth $23.58 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of IQVIA Holdings Inc to evaluate the company's liquid asset resilience ratio.
Total Liabilities of IQVIA Holdings Inc (2011–2025)
Total liabilities of IQVIA Holdings Inc from 2011 to 2025. This chart illustrates how IQVIA Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Explore IQVIA Holdings Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
IQVIA Holdings Inc Competitors by Total Liabilities
The table below lists competitors of IQVIA Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CITIC LTD. ADR/5 HD-40
F:CPF0
|
Germany | €12.08 Trillion |
|
Commerzbank AG
XETRA:CBK
|
Germany | €571.14 Billion |
|
RIO Tinto Ltd
AU:RIO
|
Australia | AU$61.12 Billion |
|
Powszechna Kasa Oszczednosci Bank Polski SA
WAR:PKO
|
Poland | zł533.98 Billion |
|
Garmin Ltd
F:GEY
|
Germany | €1.68 Billion |
|
Prudential plc
MX:PUKN
|
Mexico | MX$190.84 Billion |
|
Nokia Corp ADR
NYSE:NOK
|
USA | $16.53 Billion |
|
American International Group Inc
NYSE:AIG
|
USA | $121.11 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down IQVIA Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see IQV total asset value.
Liquidity & Leverage Metrics
IQVIA Holdings Inc Total Liabilities Ratios Explained
IQVIA Holdings Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.82 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.79 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how IQVIA Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for IQVIA Holdings Inc (2011–2025)
The table below shows the annual total liabilities of IQVIA Holdings Inc from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $23.31 Billion | +11.91% |
| 2024-12-31 | $20.83 Billion | +1.28% |
| 2023-12-31 | $20.57 Billion | +5.09% |
| 2022-12-31 | $19.57 Billion | +4.96% |
| 2021-12-31 | $18.65 Billion | +1.99% |
| 2020-12-31 | $18.28 Billion | +7.63% |
| 2019-12-31 | $16.99 Billion | +8.93% |
| 2018-12-31 | $15.60 Billion | +8.42% |
| 2017-12-31 | $14.38 Billion | +16.49% |
| 2016-12-31 | $12.35 Billion | +189.72% |
| 2015-12-31 | $4.26 Billion | +6.29% |
| 2014-12-31 | $4.01 Billion | +7.38% |
| 2013-12-31 | $3.73 Billion | -3.21% |
| 2012-12-31 | $3.86 Billion | +17.18% |
| 2011-12-31 | $3.29 Billion | -- |
About IQVIA Holdings Inc
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment of… Read more